Home       People       Ideas       Progress       News       Publications       Stats   

Dr. Robert Gendron

{Dr. Robert Gendron}
Dr. Robert Gendron

Assistant professor,
Basic Medical Sciences
Faculty of Medicine

Research Interests
Dr. Gendron's research has concentrated on molecules involved in controlling blood vessel growth and differentiation. Blood vessels are central to the growth of tumors and to the progression of a range of diseases - they support diseased tissues through a process called angiogenesis. By studying the molecules involved in controlling blood vessel growth, he aims to target this process in diseased tissues.

Through a number of collaborations, Dr. Gendron and his colleague, Dr. Hélène Paradis, have focused some of their work on studies of angiogenesis in the normal, developing and diseased eye in order to learn more about the regulation of blood vessels in health and disease in general. When blood vessels grow uncontrolled in the relatively closed environment of the eye, they can result in blindness. The identification of the novel protein tubedown-1, involved in the control of growth and differentiation of blood vessels, by Drs. Gendron and Paradis, has applications to a range of eye diseases including diabetic retinopathy. The two researchers have been funded by the National Eye Institute of the National Institutes of Health for their work on the role of tubedown-1 in retinal angiogenesis.

Born in Montreal, Robert Gendron did his B.Sc. at Concordia and McGill, and his PhD in physiology at McGill. Supported by a Medical Research Council of Canada fellowship, he continued his training at the Dana-Farber Cancer Institute in Boston in cell differentiation during embryogenesis and cancer biology. Dr. Gendron then took a faculty position at Childrens Hospital Research Foundation and University of Cincinnati College of Medicine in Ohio.

{Memorial University of Newfoundland}